Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1980 1
1982 1
1984 2
1986 1
1988 2
1989 4
1990 6
1991 4
1992 3
1993 6
1994 8
1995 1
1996 1
1997 4
1998 1
1999 4
2000 6
2001 7
2002 6
2003 11
2004 5
2005 2
2006 2
2007 4
2008 3
2009 3
2010 7
2011 7
2012 5
2013 14
2014 7
2015 11
2016 14
2017 10
2018 19
2019 27
2020 36
2021 38
2022 44
2023 47
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

352 results

Results by year

Filters applied: . Clear all
Page 1
Obesity as disruptor of the female fertility.
Silvestris E, de Pergola G, Rosania R, Loverro G. Silvestris E, et al. Among authors: de pergola g. Reprod Biol Endocrinol. 2018 Mar 9;16(1):22. doi: 10.1186/s12958-018-0336-z. Reprod Biol Endocrinol. 2018. PMID: 29523133 Free PMC article. Review.
Oral frailty and its determinants in older age: a systematic review.
Dibello V, Zupo R, Sardone R, Lozupone M, Castellana F, Dibello A, Daniele A, De Pergola G, Bortone I, Lampignano L, Giannelli G, Panza F. Dibello V, et al. Among authors: de pergola g. Lancet Healthy Longev. 2021 Aug;2(8):e507-e520. doi: 10.1016/S2666-7568(21)00143-4. Lancet Healthy Longev. 2021. PMID: 36098000 Free article. Review.
Oral frailty indicators to target major adverse health-related outcomes in older age: a systematic review.
Dibello V, Lobbezoo F, Lozupone M, Sardone R, Ballini A, Berardino G, Mollica A, Coelho-Júnior HJ, De Pergola G, Stallone R, Dibello A, Daniele A, Petruzzi M, Santarcangelo F, Solfrizzi V, Manfredini D, Panza F. Dibello V, et al. Among authors: de pergola g. Geroscience. 2023 Apr;45(2):663-706. doi: 10.1007/s11357-022-00663-8. Epub 2022 Oct 15. Geroscience. 2023. PMID: 36242694 Free PMC article. Review.
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations.
Liu D, Meyer D, Fennessy B, Feng C, Cheng E, Johnson JS, Park YJ, Rieder MK, Ascolillo S, de Pins A, Dobbyn A, Lebovitch D, Moya E, Nguyen TH, Wilkins L, Hassan A; Psychiatric Genomics Consortium Phase 3 Targeted Sequencing of Schizophrenia Study Team; Burdick KE, Buxbaum JD, Domenici E, Frangou S, Hartmann AM, Laurent-Levinson C, Malhotra D, Pato CN, Pato MT, Ressler K, Roussos P, Rujescu D, Arango C, Bertolino A, Blasi G, Bocchio-Chiavetto L, Campion D, Carr V, Fullerton JM, Gennarelli M, González-Peñas J, Levinson DF, Mowry B, Nimgaokar VL, Pergola G, Rampino A, Cervilla JA, Rivera M, Schwab SG, Wildenauer DB, Daly M, Neale B, Singh T, O'Donovan MC, Owen MJ, Walters JT, Ayub M, Malhotra AK, Lencz T, Sullivan PF, Sklar P, Stahl EA, Huckins LM, Charney AW. Liu D, et al. Among authors: pergola g. Nat Genet. 2023 Mar;55(3):369-376. doi: 10.1038/s41588-023-01305-1. Epub 2023 Mar 13. Nat Genet. 2023. PMID: 36914870 Free PMC article.
Metformin: Up to Date.
Sciannimanico S, Grimaldi F, Vescini F, De Pergola G, Iacoviello M, Licchelli B, Guastamacchia E, Giagulli VA, Triggiani V. Sciannimanico S, et al. Among authors: de pergola g. Endocr Metab Immune Disord Drug Targets. 2020;20(2):172-181. doi: 10.2174/1871530319666190507125847. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 31670618 Review.
Vasopressin in Heart Failure.
Iovino M, Iacoviello M, De Pergola G, Licchelli B, Iovino E, Guastamacchia E, Giagulli VA, Triggiani V. Iovino M, et al. Among authors: de pergola g. Endocr Metab Immune Disord Drug Targets. 2018;18(5):458-465. doi: 10.2174/1871530318666180212095235. Endocr Metab Immune Disord Drug Targets. 2018. PMID: 29437026 Review.
Endocrine-Disrupting Chemicals: Introduction to the Theme.
Lisco G, Giagulli VA, Iovino M, Guastamacchia E, Pergola G, Triggiani V. Lisco G, et al. Among authors: pergola g. Endocr Metab Immune Disord Drug Targets. 2022 Aug 15;22(7):677-685. doi: 10.2174/1871530321666210413124425. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 33847259 Review.
Covid-19 in Man: A Very Dangerous Affair.
Lisco G, Giagulli VA, De Pergola G, De Tullio A, Guastamacchia E, Triggiani V. Lisco G, et al. Among authors: de pergola g. Endocr Metab Immune Disord Drug Targets. 2021;21(9):1544-1554. doi: 10.2174/1871530321666210101123801. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 33388025 Review.
Neuroendocrine Modulation of Food Intake and Eating Behavior.
Iovino M, Messana T, Lisco G, Mariano F, Giagulli VA, Guastamacchia E, De Pergola G, Triggiani V. Iovino M, et al. Among authors: de pergola g. Endocr Metab Immune Disord Drug Targets. 2022;22(13):1252-1262. doi: 10.2174/1871530322666220127114326. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 35086464 Review.
352 results